Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

Jon C. Ogg | May 23, 2019 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: AK Steel, Amgen, Booking, Chubb, Chipotle, Expedia, Gilead, Goodyear, Philip Morris, Target, Zscaler and More

The top analyst upgrades, downgrades and initiations seen on Thursday included AK Steel, Amgen, Booking, Chubb, Chipotle Mexican Grill, Expedia,…

Chris Lange | May 21, 2019 at 9:05 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors…

Jon C. Ogg | May 16, 2019 at 7:30 AM EDT

13 Dirt Cheap Dividend Stocks Valued Under 10 Times Earnings

Here are 13 dirt cheap value stocks that are valued at less than 10 times earnings and that also pay…

Chris Lange | May 10, 2019 at 8:55 AM EDT

Short Sellers Back Off Major Biotechs

The April 30 short interest data have been compared with the previous report, and short interest in most of these…

Lee Jackson | May 6, 2019 at 7:05 AM EDT

Jefferies Top Stocks to Buy Include 2 Red-Hot Marijuana Companies

These five top stocks to Buy have solid upside potential, and some of them appear to have put some past…

Jon C. Ogg | May 2, 2019 at 4:53 PM EDT

Is Gilead’s Stock and Revenue Free-Fall Finally Bottoming Out?

It’s no simple task for a biotech giant to try to sell itself to investors as a value stock. That…

Chris Lange | Apr 26, 2019 at 9:40 AM EDT

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The April 15 short interest data have been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Apr 24, 2019 at 12:55 PM EDT

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

24/7 Wall St. has looked over some of the biotech sector's laggards, and we have also looked over the top…

Lee Jackson | Apr 23, 2019 at 7:40 AM EDT

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Jefferies did a deep dive into the health care sector, looking for underperforming stocks that could hold some solid value…

Chris Lange | Apr 10, 2019 at 9:15 AM EDT

Big Biotechs Confound Short Sellers

The March 29 short interest data have been compared with the previous report, and short interest moves in these selected…

Jon C. Ogg | Apr 10, 2019 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Disney, Gilead, Nordstrom, Novartis, Tesla, Under Armour, Wendy’s and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Gilead Sciences, Nordstrom, Novartis, Tesla, Under Armour, Walt…

Chris Lange | Mar 27, 2019 at 8:30 AM EDT

Big Biotechs Scare Off Short Sellers

The March 15 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Mar 12, 2019 at 9:05 AM EDT

Major Biotechs See a Rising Tide in Short Interest

The February 28 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Feb 28, 2019 at 8:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The February 15 short interest data…

Chris Lange | Feb 12, 2019 at 9:55 AM EST

Short Sellers Run for Cover From Major Biotechs

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data…

1 … 12 13 14 15 16 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades and Downgrades: AK Steel, Amgen, Booking, Chubb, Chipotle, Expedia, Gilead, Goodyear, Philip Morris, Target, Zscaler and More

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

13 Dirt Cheap Dividend Stocks Valued Under 10 Times Earnings

Short Sellers Back Off Major Biotechs

Jefferies Top Stocks to Buy Include 2 Red-Hot Marijuana Companies

Is Gilead’s Stock and Revenue Free-Fall Finally Bottoming Out?

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Big Biotechs Confound Short Sellers

Top Analyst Upgrades and Downgrades: Apple, Disney, Gilead, Nordstrom, Novartis, Tesla, Under Armour, Wendy’s and More

Big Biotechs Scare Off Short Sellers

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Gilead Sciences : GILD

All Gilead Sciences Articles

Top Analyst Upgrades and Downgrades: AK Steel, Amgen, Booking, Chubb, Chipotle, Expedia, Gilead, Goodyear, Philip Morris, Target, Zscaler and More

Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More

13 Dirt Cheap Dividend Stocks Valued Under 10 Times Earnings

Short Sellers Back Off Major Biotechs

Jefferies Top Stocks to Buy Include 2 Red-Hot Marijuana Companies

Is Gilead’s Stock and Revenue Free-Fall Finally Bottoming Out?

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

Why 5 Lagging Health Care Giants May Be Incredible Buys Now

Big Biotechs Confound Short Sellers

Top Analyst Upgrades and Downgrades: Apple, Disney, Gilead, Nordstrom, Novartis, Tesla, Under Armour, Wendy’s and More

Big Biotechs Scare Off Short Sellers

Major Biotechs See a Rising Tide in Short Interest

Short Sellers Can’t Make Up Their Minds on Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do